EXEL
EXELIXIS, INC.
NASDAQ · Healthcare · Biotechnology · US
$62.68
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- 16.44x
- P/E 2026E
- 17.66x
- P/E 2027E
- 15.19x
- P/E 2028E
- 11.96x
- P/S forward
- 5.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.05x
- PEG TTM
- 1.19x
- Price / book
- 8.42x
- Price / sales
- 6.38x
- Price / cash flow
- 13.12x
Enterprise value
- Enterprise value
- $14.9B
- EV / sales
- 6.10x
- EV / EBITDA
- 14.19x
- EV / EBIT
- 15.29x
- Market cap
- $15.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026